Intended for US audience only.
They made the ADVATE choice
Karen Chicago, IL
Years ago, both my sons Nick and Cody were born with severe hemophilia A. Today, Nick is 20 and loves working out and playing basketball**. Cody is 15, and is a student who enjoys rockin’ out on his guitar and working out like his big brother. In our home on the northwest side of the city, we spend a lot of family time together just hanging out.
I made The ADVATE Choice because it gives me a sense of calm. As my sons grow older and spend more and more time on their own, I feel secure knowing that ADVATE is their therapy.
Gregg Chicago, IL
Born and raised in the city, my wife Sheree and I live in a downtown loft just a short ride from Mom and Dad. Though you could call me accomplished in my 10 year sales career with a worldwide logistics and sourcing company, I’d describe myself as “one of the guys.” When I’m not traveling or working, I like to bowl and play basketball and softball**. Spending time with my family is also important to me.
I made The ADVATE Choice because it gives me more time to spend on the things that really matter. As my family grows, I want a therapy that allows me to look forward to the future with confidence.
Seth Lincoln, NE
Between school, work, and hanging out with friends, I’m a busy guy. I work at the bank, and recently, I took on a part-time job managing promotional events. I also work out, swim**, and travel a lot to see my family in California. I’ve lived in Lincoln my entire life, so every Saturday in the fall, you’ll find me cheering on the Cornhuskers with my family and friends.
As a student, my schedule can be challenging. I choose ADVATE because it helps me manage my bleeds so that I can get back to the activity I'm doing, whether it's swimming, studying, or hanging out with friends.
* There have been no confirmed reports of viral transmission with recombinant factor VIII therapies.
** Not all activities are appropriate for all people. Consult with your physician or healthcare professional to determine which activities are appropriate for you and what safety precautions to take when participating in a particular sport or exercise regimen.
Share your story ADVATE therapy's array of benefits
Indications:
ADVATE [Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method] is indicated in hemophilia A (classical hemophilia) for the control and prevention of bleeding episodes and for perioperative management of adults and children with hemophilia A.
ADVATE is not indicated for the treatment of von Willebrand’s disease.
Important Safety Information:
Let your doctor know if you have had any previous allergic reactions to other factor VIII products or mouse or hamster proteins.
There is a possibility that you can have an allergic reaction to ADVATE. Symptoms of an allergic reaction may include rash, hives, itching, tightness in throat or chest, difficulty breathing, feeling dizzy or light-headed, or a weak pulse. Anaphylaxis, a severe and potentially life-threatening allergic reaction, is possible. If you experience any of these symptoms, stop the infusion immediately and promptly contact your doctor.
The formation of inhibitors has been observed with all factor VIII products, including ADVATE. Contact your doctor if you are not able to prevent or control bleeding episodes with your regular doses of factor VIII therapy.
The most serious adverse reactions seen with ADVATE are chest pain and fever. The most common adverse reactions observed include nausea and vomiting, upper respiratory-type infection, fever, accident and injury, joint pain and swelling, headache, limb pain, and cough.
ADVATE Full Prescribing Information (PDF).
To view the PDFs, you will need
References: 1. Industry, financial, and research reports on file. Westlake Village, CA: Baxter Healthcare Corporation. 2. The National Hemophilia Foundation. MASAC Recommendations Concerning the Treatment of Hemophilia and Other Bleeding Disorders. MASAC Document #187, November 2008. 3. McCormack PL, Plosker GL. Octocog alpha, plasma/albumin-free method. Drugs. 2005;65:2613-2620. 4. ADVATE Prescribing Information. Westlake Village, CA: Baxter Healthcare Corporation; July 2007. 5. Tarantino MD, Collins PW, Hay CRM, et al, and the rAHF-PFM Clinical Study Group. Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A. Haemophilia. 2004;10:428-437. 6. Shapiro AD. Anti-hemophilic factor (recombinant), plasma/albumin-free method (octocog-alpha; ADVATE) in the management of hemophilia A. Vasc Health Risk Manag. 2007;3(5):555-565. 7. Data on File. Westlake Village, CA: Baxter Healthcare Corporation.
